e-Health Intervention for Cancer of the Female Reproductive System
Trial Summary
What is the purpose of this trial?
This trial studies how well the 'Day by Day' online program helps patients with advanced gynecologic cancer manage their fears about cancer progression. The program includes group sessions, self-study activities, and periodic updates to teach skills for reducing anxiety and worries.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the e-Health Intervention (Day-by-Day) treatment for cancer of the female reproductive system?
Research shows that online interventions can improve health outcomes like quality of life and symptom management for patients with gynecological cancers. Additionally, digital health strategies have been effective in enhancing the quality of life for breast cancer survivors, suggesting potential benefits for similar interventions in other female reproductive cancers.12345
Is the e-Health Intervention generally safe for humans?
How is the e-Health Intervention (Day-by-Day) treatment different from other treatments for cancer of the female reproductive system?
The e-Health Intervention (Day-by-Day) is unique because it leverages digital technology to provide accessible, tailored support and information for women with gynecological cancer, potentially improving their quality of life and addressing psychosocial and physical burdens in a way that traditional treatments may not.2341112
Research Team
Anne Reb
Principal Investigator
City of Hope Medical Center
Eligibility Criteria
This trial is for English-speaking women over 18 with stage III or IV gynecologic cancer (ovarian, endometrial, cervical, vulvar/vaginal), at least 3 months post-diagnosis. They must have significant fear of their cancer progressing as measured by a specific questionnaire. Those in hospice care, with severe depression, or unable to follow the study plan are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Development
Patients complete surveys and participate in focus groups to adapt the intervention into a hybrid format
DBD Intervention
Patients receive DBD intervention consisting of group and web-based self-study sessions, check-in calls, videos, and handouts
Follow-up
Participants are monitored for fear of progression and secondary outcomes such as distress, anxiety, and depression
Treatment Details
Interventions
- e-Health Intervention (Day-by-Day)
Find a Clinic Near You
Who Is Running the Clinical Trial?
City of Hope Medical Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator